NCT04351282View on ClinicalTrials.gov

SBRT for Oligo-metastatic Lesions After Systemic Treatment of Primary Metastatic Nasopharyngeal Carcinoma

NANot yet recruitingINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Nasopharyngeal CarcinomaMetastasisStereotactic Body Radiation Therapy
Interventions
RADIATION

SBRT

SBRT for oligometastatic lesions will be assigned to those who got PR,SD after systemic treatment.

Trial Locations (1)

200032

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT04351282 - SBRT for Oligo-metastatic Lesions After Systemic Treatment of Primary Metastatic Nasopharyngeal Carcinoma | Biotech Hunter | Biotech Hunter